Filing Details
- Accession Number:
- 0001415889-24-026701
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-13 16:28:31
- Reporting Period:
- 2024-11-11
- Accepted Time:
- 2024-11-13 16:28:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1811063 | Nuvation Bio Inc. | NUVB | Pharmaceutical Preparations (2834) | 850862255 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2017749 | Jerry Junyuan Wang | C/O Nuvation Bio Inc. 1500 Broadway, Suite 1401 New York NY 10036 | Ceo, Anheart Therapeutics Ltd. | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2024-11-11 | 56,361 | $2.89 | 3,866,228 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Class A Common Stock | 2,246,458 | Indirect | By LLC |
Footnotes
- The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of performance-based restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary transactions by the Reporting Person.
- Shares are held directly by WangWang, LLC, of which the Reporting Person is Manager.
Billionaire Hedge Funds
